Canton Strategic Holdings, Inc. (CNTN) Fair Value 2026

CNTN · Biotechnology ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

4.2 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (21/100)

Quick Summary — As of 2026-08-28, Canton Strategic Holdings, Inc. (CNTN) trades at $2.22. QOC: 4.2/10. Value Trap Risk: 21/100 (SAFE). 0/13 models active.

Key Facts

Ticker
CNTN
Price
$2.22
Quality Score
4.2/10
Value Trap Risk
21/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 4.2/10 signals weak fundamentals

What Fair Value Does Each Model Give CNTN?

0 Intrinsic Value Models vs. Current Price ($2.22)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Canton Strategic Holdings, Inc. (CNTN) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Canton Strategic Holdings, Inc. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About CNTN?

0 of 13 models are currently active for CNTN. See which stocks rank higher →

How Does CNTN Rank in Biotechnology?

Among 625 Biotechnology stocks, CNTN ranks #515 by Quality of Company score. CirclFi's QOC score of 4.2/10 evaluates 32 fundamental signals. A score of 4.2 reflects mixed fundamentals.

See all Most Undervalued Biotechnology Stocks →

Within the Biotechnology space, Canton Strategic Holdings, Inc. competes in an environment where cash runway (months) often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is CNTN a Value Trap?

CirclFi's Value Trap algorithm assigns CNTN a score of 21/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Canton Strategic Holdings, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Canton Strategic Holdings, Inc. is rated at 4.2/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every CNTN valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Canton Strategic Holdings, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Biotechnology Stocks Should You Also Analyze?

11 related Biotechnology stocks with 13-model coverage

RNTXRein Therapeutics Inc.QOC 4.2AKTXAkari Therapeutics, PlcQOC 4.1HUMAHumacyte, Inc.QOC 4.2ARMPArmata Pharmaceuticals, Inc.QOC 4.1BHVNBiohaven Ltd.QOC 4.2GTBPGT Biopharma, Inc.QOC 4.1SEERSeer, Inc.QOC 7.0SCNIScinai Immunotherapeutics Ltd.QOC 5.6PGENPrecigen, Inc.QOC 4.9EXELExelixis, Inc.QOC 9.6INCYIncyte CorporationQOC 9.5

Read investment analysis: RNTX · AKTX · HUMA · ARMP · BHVN · GTBP · SEER · SCNI · PGEN · EXEL · INCY

Which Other Stocks Have a Similar Quality Score to CNTN?

7 companies across all industries closest to CNTN’s Quality of Company score of 4.2/10.

VNETVNET Group, Inc.QOC 4.2CSBACSBAQOC 4.2NUMDNu-Med Plus, Inc.QOC 4.2CSUICannabis Suisse Corp.QOC 4.1CNFNCFN Enterprises Inc.QOC 4.2RIMEAlgorhythm Holdings, Inc.QOC 4.1NVDANVIDIA CorporationQOC 10.0

Read investment analysis: VNET · CSBA · NUMD · CSUI · CNFN · RIME · NVDA

Where Does CNTN Sit in CirclFi's Biotechnology Rankings?

CNTN is ranked against every other Biotechnology stock CirclFi covers in each of these screens.

See all Biotechnology stocks ranked →

What Else Do Investors Ask About Canton Strategic Holdings, Inc.’s Valuation?

What is Canton Strategic Holdings, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Canton Strategic Holdings, Inc. (CNTN). The Quality of Company score is 4.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is CNTN overvalued or undervalued right now?

At $2.22, 0 of 0 active models suggest CNTN may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Canton Strategic Holdings, Inc.'s business model in Biotechnology.

What does a Quality of Company score of 4.2 mean for CNTN?

Canton Strategic Holdings, Inc.'s QOC of 4.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on CNTN?

CirclFi analyzes CNTN with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is CNTN a value trap in 2026?

Canton Strategic Holdings, Inc.'s Value Trap score is 21/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Canton Strategic Holdings, Inc. (CNTN) a Quality of Company score of 4.2/10 across 32 fundamental signals as of 2026-08-28.” Source: circlfi.com/stock/CNTN/ · Methodology
Primary sources for this CNTN valuation
  • Financial statements: Canton Strategic Holdings, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001861657) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for CNTN as of ; valuations recomputed .